Nobel Prize boosts regenerative medicine in Japan
Fujifilm and Takeda Pharmaceutical have been building on Shinya Yamanaka's discovery and are planning clinical trials to try out new therapies using this technology
Tokyo
FOUR years ago, Shinya Yamanaka received a phone call that would forever change his destiny. The Kyoto University professor had won a Nobel Prize for his work in stem cell biology, which has since sparked a torrent of investment into regenerative medicine in Japan, a fast-moving field which the country's pharmaceutical industry aims to dominate.
Regenerated skin and cartilage are already used in Japanese patients, while corneas are expected to become available from 2018 and lab-grown livers and other organs in the years ahead.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
Are floating cities the solution to rising seas?
Apple scores win in labor case involving fired retail workers
Brokers’ take: DBS cuts Venture Corp price target after Q1 earnings miss
Garmin’s Q1 results beat on strong demand for fitness, auto products
Foxconn’s musical chairs sound like punk rock
US sets up board to advise on safe, secure use of AI